|
1
|
Feng J, Ma T, Ge Z, Lin J, Ding W, Chen H,
Zhu W, Zhou S and Tan Y: PKM2 gene regulates the behavior of
pancreatic cancer cells via mitogen-activated protein kinase
pathways. Mol Med Rep. 11:2111–2117. 2015.PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim J, Kim YC, Fang C, Russell RC, Kim JH,
Fan W, Liu R, Zhong Q and Guan KL: Differential regulation of
distinct Vps34 complexes by AMPK in nutrient stress and autophagy.
Cell. 152:290–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gong L, Yang B, Xu M, Cheng B, Tang X,
Zheng P, Jing Y and Wu GJ: Bortezomib-induced apoptosis in cultured
pancreatic cancer cells is associated with ceramide production.
Cancer Chemother Pharmacol. 73:69–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Min H, Xu M, Chen ZR, Zhou JD, Huang M,
Zheng K and Zou XP: Bortezomib induces protective autophagy through
AMP-activated protein kinase activation in cultured pancreatic and
colorectal cancer cells. Cancer Chemother Pharmacol. 74:167–176.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin C, Yao L, Long J, Fu DL, Yu XJ, Yang
F, Ni QX and Xu J: Effect of multiple-phase regional intra-arterial
infusion chemotherapy on patients with resectable pancreatic head
adenocarcinoma. Chin Med J (Engl). 122:284–290. 2009.PubMed/NCBI
|
|
7
|
Preis M and Korc M: Signaling pathways in
pancreatic cancer. Crit Rev Eukaryot Gene Expr. 21:115–129. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seidah NG and Prat A: The biology and
therapeutic targeting of the proprotein convertases. Nat Rev Drug
Discov. 11:367–383. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsuji A, Sakurai K, Kiyokage E, Yamazaki
T, Koide S, Toida K, Ishimura K and Matsuda Y: Secretory proprotein
convertases PACE4 and PC6A are heparin-binding proteins which are
localized in the extracellular matrix. Potential role of PACE4 in
the activation of proproteins in the extracellular matrix. Biochim
Biophys Acta. 1645:95–104. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuasa K, Masuda T, Yoshikawa C, Nagahama
M, Matsuda Y and Tsuji A: Subtilisin-like proprotein convertase
PACE4 is required for skeletal muscle differentiation. J Biochem.
146:407–415. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sato H, Kinoshita T, Takino T, Nakayama K
and Seiki M: Activation of a recombinant membrane type 1-matrix
metalloproteinase (MT1-MMP) by furin and its interaction with
tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett.
393:101–104. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yana I and Weiss SJ: Regulation of
membrane type-1 matrix metalloproteinase activation by proprotein
convertases. Mol Biol Cell. 11:2387–2401. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dubois CM, Blanchette F, Laprise MH, Leduc
R, Grondin F and Seidah NG: Evidence that furin is an authentic
transforming growth factor-beta1-converting enzyme. Am J Pathol.
158:305–316. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khatib AM, Siegfried G, Prat A, Luis J,
Chrétien M, Metrakos P and Seidah NG: Inhibition of proprotein
convertases is associated with loss of growth and tumorigenicity of
HT-29 human colon carcinoma cells: Importance of insulin-like
growth factor-1 (IGF-1) receptor processing in IGF-1-mediated
functions. J Biol Chem. 276:30686–30693. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hubbard FC, Goodrow TL, Liu SC, Brilliant
MH, Basset P, Mains RE and Klein-Szanto AJ: Expression of PACE4 in
chemically induced carcinomas is associated with spindle cell tumor
conversion and increased invasive ability. Cancer Res.
57:5226–5231. 1997.PubMed/NCBI
|
|
16
|
Mahloogi H, Bassi DE and Klein-Szanto AJ:
Malignant conversion of non-tumorigenic murine skin keratinocytes
overexpressing PACE4. Carcinogenesis. 23:565–572. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
D'Anjou F, Routhier S, Perreault JP, Latil
A, Bonnel D, Foumier I, Salzet M and Day R: Molecular validation of
PACE4 as a target in prostate cancer. Transl Oncol. 4:157–172.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Klee EW, Bondar OP, Goodmanson MK, Dyer
RB, Erdogan S, Bergstralh EJ, Bergen HR III, Sebo TJ and Klee GG:
Candidate serum biomarkers for prostate adenocarcinoma identified
by mRNA differences in prostate tissue and verified with protein
measurements in tissue and blood. Clin Chem. 58:599–609. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Estilo CL, O-charoenrat P, Talbot S, Socci
ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y,
Boyle JO, et al: Oral tongue cancer gene expression profiling:
Identification of novel potential prognosticators by
oligonucleotide microarray analysis. BMC Cancer. 9:112009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kurokawa Y, Matoba R, Nakamori S, Takemasa
I, Nagano H, Dono K, Umeshita K, Sakon M, Monden M and Kato K:
PCR-array gene expression profiling of hepatocellular carcinoma. J
Exp Clin Cancer Res. 23:135–141. 2004.PubMed/NCBI
|
|
21
|
Delic S, Lottmann N, Jetschke K,
Reifenberger G and Riemenschneider MJ: Identification and
functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma
invasion-associated candidate genes. Neuropathol Appl Neurobiol.
38:201–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bassi DE, De Cicco R Lopez, Cenna J,
Litwin S, Cukierman E and Klein-Szanto AJ: PACE4 expression in
mouse basal keratinocytes results in basement membrane disruption
and acceleration of tumor progression. Cancer Res. 65:7310–7319.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tait SW and Green DR: Mitochondria and
cell death: Outer membrane permeabilization and beyond. Nat Rev Mol
Cell Biol. 11:621–632. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
LaCasse EC, Mahoney DJ, Cheung HH,
Plenchette S, Baird S and Korneluk RG: IAP-targeted therapies for
cancer. Oncogene. 27:6252–6275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boonyarat C, Yenjai C, Vajragupta O and
Waiwut P: Heptaphylline induces apoptosis in human colon
adenocarcinoma cells through bid and Akt/NF-kB (p65) pathways.
Asian Pac J Cancer Prev. 15:10483–10487. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Serrano ML, Sánchez-Gómez M, Bravo MM,
Yakar S and LeRoith D: Differential expression of IGF-I and insulin
receptor isoforms in HPV positive and negative human cervical
cancer cell lines. Horm Metab Res. 40:661–667. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cotter TG: Apoptosis and cancer: The
genesis of a research field. Nat Rev Cancer. 9:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leber B, Lin J and Andrews DW: Still
embedded together binding to membranes regulates Bcl-2 protein
interactions. Oncogene. 29:5221–5230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang H, Zhao PJ, Su D, Feng J and Ma SL:
Paris saponin I induces apoptosis via increasing the Bax/Bcl-2
ratio and caspase-3 expression in gefitinib-resistant non-small
cell lung cancer in vitro and in vivo. Mol Med Rep. 9:2265–2272.
2014.PubMed/NCBI
|
